Global shifts in protein sumoylation in response to electrophile and oxidative stress

被引:121
作者
Manza, LL
Codreanu, SG
Stamer, SL
Smith, DL
Wells, KS
Roberts, RL
Liebler, DC
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA
[6] Univ Arizona, Dept Pharmacol & Toxicol, Coll Pharm, Tucson, AZ 85721 USA
关键词
D O I
10.1021/tx049767l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Human small ubiquitin-like modifier (sumo) proteins include sumo-1 and the less studied, nearly identical sumo-2 and sumo-3 proteins. Whereas the structurally related ubiquitin molecule targets proteins for degradation, sumo provides a distinct, yet poorly understood regulatory signal. Protein sumoylation is sensitive to diverse cellular stresses, yet the targets of sumoylation in stress are unknown. We studied protein sumoylation in HEK293 cells exposed to hydrogen peroxide, alkylating agents, and the lipid oxidation-derived electrophile 4-hydroxynonenal, which is an ubiquitous product of lipid oxidation associated with oxidative stress. Confocal immunofluorescence microscopy indicated that in unstressed cells sumo-1 targeted nuclear proteins, whereas sumo-2/3 targeted proteins in both nuclei and cytoplasm. Western blot analyses revealed changes in sumo-1 and sumo-2/3 targeting patterns with stress. We used immunoaffinity chromatography to harvest sumo-associated proteins from HA-sumo-1-and HA-sumo-3-expressing HEK293 cells both before and after treatment with 4-hydroxynonenal. Multidimensional liquid chromatography-tandem mass spectrometry analyses identified 54 HA-sumo-1-associated proteins and 38 HA-sumo-3-associated proteins. Major protein targets included RNA binding and processing proteins, transcription factors, metabolic enzymes, and cytoskeletal regulators. Treatment with 4-hydroxynonenal caused a near-complete redistribution of sumo-1 and sumo-3 to different protein targets., which included chaperones, antioxidant, and DNA damage signaling proteins. A 10-15% overlap of sumo-1 and sumo-3 targets before and after stress suggests that sumo proteins target distinct protein groups. The results suggest that reactive electrophiles not only directly modify proteins but also lead to indirect changes in endogenous protein modifications that regulate protein functions.
引用
收藏
页码:1706 / 1715
页数:10
相关论文
共 45 条
[1]   Toward a human blood serum proteome - Analysis by multidimensional separation coupled with mass spectrometry [J].
Adkins, JN ;
Varnum, SM ;
Auberry, KJ ;
Moore, RJ ;
Angell, NH ;
Smith, RD ;
Springer, DL ;
Pounds, JG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (12) :947-955
[2]   A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus [J].
Bohren, KM ;
Nadkarni, V ;
Song, JH ;
Gabbay, KH ;
Owerbach, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :27233-27238
[3]   Prostaglandin H2 (PGH2) accelerates formation of amyloid β1-42 oligomers [J].
Boutaud, O ;
Ou, JJ ;
Chaurand, P ;
Caprioli, RM ;
Montine, TJ ;
Oates, JA .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (04) :1003-1006
[4]   Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].
Conway, KA ;
Rochet, JC ;
Bieganski, RM ;
Lansbury, PT .
SCIENCE, 2001, 294 (5545) :1346-1349
[5]   Protein quality control:: U-box-containing E3 ubiquitin ligases join the fold [J].
Cyr, DM ;
Höhfeld, J ;
Patterson, C .
TRENDS IN BIOCHEMICAL SCIENCES, 2002, 27 (07) :368-375
[6]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239
[7]   Modification of CCAAT/enhancer-binding protein-β by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3 [J].
Eaton, EM ;
Sealy, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) :33416-33421
[8]   Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development [J].
Evans, DC ;
Watt, AP ;
Nicoll-Griffith, DA ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (01) :3-16
[9]   Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis [J].
Fusaro, G ;
Wang, S ;
Chellappan, S .
ONCOGENE, 2002, 21 (29) :4539-4548
[10]   Changes in the protein expression of yeast as a function of carbon source [J].
Gao, J ;
Opiteck, GJ ;
Friedrichs, MS ;
Dongre, AR ;
Hefta, SA .
JOURNAL OF PROTEOME RESEARCH, 2003, 2 (06) :643-649